Gujarat Kidney and Super Speciality debuted on stock exchanges with a 6% premium, opening at Rs 120.75 on BSE and Rs 120 on NSE, against its IPO price of Rs 114. The Rs 251 crore IPO saw healthy investor participation, driven by strong retail demand, despite muted grey market signals.
Fed can afford to stay patient as inflation risks ease: Steve Englander
The Federal Reserve is unlikely to alter interest rates soon, as inflation moderates and the economy remains stable, according to Steve Englander of Standard Chartered.